Pharming (PHAR) EBITDA Margin (2020 - 2026)
Pharming's EBITDA Margin came in at 1.57% for Q2 2026, down 3.70 percentage points from 5.27% a year earlier.
Powered by 
Analysis
Pharming (PHAR) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Pharming reported EBITDA Margin of 6.78%, up 3.77 percentage points year-over-year; for FY2025, it came in at 9.85%, up 9.59 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -29.87 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 0.26% in FY2024 (-4.04 pp), 4.30% in FY2023 (-15.93 pp), 20.23% in FY2022 (+1.72 pp) and 18.51% in FY2021 (-21.21 pp).
- The Q2 2026 figure represents the lowest quarterly EBITDA Margin since Q2 2024.
- Year-over-year, EBITDA Margin increased in three of the last five quarters, with an average year-over-year change of +4328111.35 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 18630234.69 percentage points), and the weakest in Q4 2025 (a drop of 5294958.64 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn | 1.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57% |
| Dec 31, 2025 | 3,010,334.46% |
| Jun 30, 2025 | 5.27% |
| Dec 31, 2024 | 8,305,293.10% |
| Sep 30, 2024 | 9.15% |
| Jun 30, 2024 | -18,630,229.42% |
| Dec 31, 2023 | 10.66% |
| Sep 30, 2023 | 7.22% |
| Dec 31, 2022 | -14.67% |
| Sep 30, 2022 | 17.99% |
| Dec 31, 2021 | -10.00% |
| Sep 30, 2021 | -11.57% |
| Dec 31, 2020 | 37.99% |
| Sep 30, 2020 | 45.11% |
API Access
Pharming EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();